
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $48.4M | -- | -- | -- | -- |
08/07/2025 | Q2 | $46.8M | -- | -- | -- | -- |
05/07/2025 | Q1 | $43.8M | $48.3M | $0.10 | -- | -- |
03/26/2025 | Q4 | $40.6M | $48.3M | $0.06 | -- | -- |
11/05/2024 | Q3 | $38.3M | $46.9M | $0.06 | -- | -- |
08/07/2024 | Q2 | $36.5M | $45.3M | $0.06 | -- | -- |
05/08/2024 | Q1 | $39.2M | $39.9M | $0.07 | -- | -- |
03/20/2024 | Q4 | $43M | $33.9M | $0.05 | -- | -- |
11/08/2023 | Q3 | -- | -- | $0.06 | -- | -- |
08/02/2023 | Q2 | -- | -- | $0.06 | -- | -- |
05/03/2023 | Q1 | -- | -- | $0.09 | -- | -- |
03/16/2023 | Q4 | -- | -- | $0.22 | -- | -- |
11/03/2022 | Q3 | -- | -- | $0.12 | -- | -- |
08/03/2022 | Q2 | -- | -- | $0.14 | -- | -- |
05/11/2022 | Q1 | -- | -- | $0.10 | -- | -- |
03/16/2022 | Q4 | -- | -- | $0.10 | -- | -- |
11/03/2021 | Q3 | -- | -- | $0.12 | -- | -- |
08/04/2021 | Q2 | -- | -- | $0.08 | -- | -- |
05/05/2021 | Q1 | -- | -- | $0.07 | -- | -- |
03/23/2021 | Q4 | -- | -- | $0.06 | -- | -- |
11/05/2020 | Q3 | -- | -- | $0.11 | $0.04 | $0.07 |
08/06/2020 | Q2 | -- | -- | $0.02 | $0.02 | -- |
05/12/2020 | Q1 | -- | -- | $0.04 | $0.04 | -- |
03/24/2020 | Q4 | -- | -- | $0.02 | -- | -- |
11/12/2019 | Q3 | -- | -- | $0.04 | -- | -- |
08/19/2019 | Q2 | -- | -- | $0.02 | -- | -- |
05/20/2019 | Q1 | -- | -- | $0.01 | -- | -- |
12/31/2018 | Q4 | -- | -- | $0.02 | -- | -- |
09/30/2018 | Q3 | -- | -- | -$0.02 | -- | -- |
06/30/2018 | Q2 | -- | -- | $0.01 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.01 | -- | -- |
12/31/2017 | Q4 | -- | -- | $0.03 | -- | -- |
09/30/2017 | Q3 | -- | -- | $0.02 | -- | -- |
07/13/2017 | Q2 | -- | -- | $0.01 | -- | -- |
05/15/2017 | Q1 | -- | -- | $0.01 | -- | -- |
12/31/2016 | Q4 | -- | -- | -$0.08 | -- | -- |
09/30/2016 | Q3 | -- | -- | -$0.12 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$0.04 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.06 | -- | -- |
03/30/2016 | Q4 | -- | -- | -$0.07 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$0.04 | -- | -- |
Envela reported $48.3M worth of top line sales in its most recent quarter.
Envela announced earnings per share of $0.10 which represents a beat of analyst forecast a -- per share.
Envela reported $12M that represents $0.46 per share over the last quarter.
Envela's earnings are forecast to grow from $0.26 per share to -- per share next year representing an increase of --.
Envela's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.